Statistics
Publications
31
Citations
1.5K
H-Index
22
Active since
2000
Donghwa Kim is an author at Seoul National University specializing in pharmacology, molecular oncology, and oncology.
Publications per year
2000–2021
31
31
Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells
Sangkil Nam, Donghwa Kim, Jin Cheng et al. · Cancer Research · 2005 · 374 citations · Full text
Medicine, Oncology, Pharmacology +17
Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer.
Donghwa Kim, George Z. Cheng, Craig W. Lindsley et al. · PubMed · 2005 · 80 citations
1–5 of 31